BioMarin

In News

1cBio Received Shareholder Proceeds Upon Closing of BioMarin Pharmaceutical Inc.'s Acquisition of Alesta Therapeutics - Yahoo Finance

Yahoo Finance - Oct 14, 2026

BioMarin lays off 117 California workers to consolidate footprint - Fierce Pharma

Fierce Pharma - Sep 30, 2026

BMRN Stock Rises On Up To $490M Alesta Deal, But Analyst Cuts Price Target To $59 — Here’s Why - Stocktwits

Stocktwits - Oct 16, 2026

Major North Bay biotech employer to cut 119 jobs in consolidation move - The Press Democrat

The Press Democrat - Sep 30, 2026

What BioMarin Shares New VOXZOGO Data Means For Shareholders - Simply Wall Street

Simply Wall Street - Oct 13, 2026

BIOMARIN PHARMACEUTICAL INC (NASDAQ:BMRN) Screens as a Decent Value Stock on Cheap Forward Earnings - ChartMill

ChartMill - Oct 13, 2026

1cBio Receives Proceeds from BioMarin’s Acquisition of Alesta Therapeutics, Retains Milestone and Royalty Rights - citybiz

citybiz - Oct 14, 2026

BioMarin Appoints Cara Bauer as Chief People Officer - PR Newswire

PR Newswire - Oct 05, 2026

UBS Adjusts BioMarin Pharmaceutical Price Target to $88 From $114, Maintains Buy Rating - Yahoo Finance

Yahoo Finance - Oct 15, 2026

Ascendis to pay 20% Yuviwel royalties in patent settlement with BioMarin - Fierce Pharma

Fierce Pharma - Aug 31, 2026

BioMarin Pharmaceutical Inc. (BMRN) Options Chain - Yahoo! Finance Canada

Yahoo! Finance Canada - Oct 14, 2026

Biomarin Pharmaceutical Inc. (BM8.SG) Q2 FY2026 earnings call transcript - Yahoo Finance

Yahoo Finance - Oct 15, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment